Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma-Reference-Cited by-同舟云学术

Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma

Published:2015-05-12 Issue:24 Volume:6 Page:20555-20569
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Sibbesen Nina A.¹,Kopp Katharina L.¹,Litvinov Ivan V.²,Jønson Lars³,Willerslev-Olsen Andreas¹,Fredholm Simon¹,Petersen David L.¹,Nastasi Claudia¹,Krejsgaard Thorbjørn¹,Lindahl Lise M.⁴,Gniadecki Robert⁵,Mongan Nigel P.⁶,Sasseville Denis²,Wasik Mariusz A.⁷,Iversen Lars⁴,Bonefeld Charlotte M.¹,Geisler Carsten¹,Woetmann Anders¹,Odum Niels¹

Affiliation:

1. Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark

2. Division of Dermatology, McGill University Health Centre, Montréal, Quebec, Canada

3. Department of Molecular Medicine, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark

4. Department of Dermatology, Aarhus University Hospital, Skejby, Aarhus, Denmark

5. Department of Dermatology, Copenhagen University Hospital, Bispebjerg, Copenhagen, Denmark

6. Faculty of Medicine and Health Science, School of Veterinary Medicine and Science, University of Nottingham, Loughborough, United Kingdom

7. Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-coding RNAs in the spotlight of the pathogenesis, diagnosis, and therapy of cutaneous T cell lymphoma;Cell Death Discovery;2024-09-10

2. From Molecules to Microbes: Tracing Cutaneous T-Cell Lymphoma Pathogenesis through Malignant Inflammation;Journal of Investigative Dermatology;2024-09

3. The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets;Cells;2024-03-28

4. Stark juckende Mycosis fungoides erfolgreich mit Upadacitinib behandelt;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-03

5. Severely pruritic mycosis fungoides successfully treated with upadacitinib;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-02-07